{"DataElement":{"publicId":"2008046","version":"2","preferredName":"Breast Carcinoma In Situ Histology","preferredDefinition":"Histology of the In Situ component of a breast cancer sample or lesion.","longName":"BRST_CA_IN_SITU_HIST","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"2186389","version":"1","preferredName":"Breast Carcinoma Histology","preferredDefinition":"Histology or differentiation of a breast cancer specimen.","longName":"BRST_CA_HIST","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2475941","version":"1","preferredName":"Breast Carcinoma","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit.  Breast carcinoma may affect both females and males.  It is the most common malignant tumor and the leading cause of carcinoma death in women.  Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation.  The widespread use of mammography has contributed in the detection of very early cancerous lesions (less than 2mm in diameter).  The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular).  Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route.  The most common site of lymph node involvment is the axilla.  Breast carcinomas infrequently occur in males (particularly elderly individuals and patients with Klinefelter's syndrome).  The therapy of breat carcinoma includes surgery, radiation therapy, hormonal therapy and chemotherapy, depending on the type and extend of the disease. --2002","longName":"C4872","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Carcinoma","conceptCode":"C4872","definition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"11C95199-159B-5C1E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-19","modifiedBy":"ONEDATA","dateModified":"2006-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2186387","version":"1","preferredName":"Histology","preferredDefinition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","longName":"C16681","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histology","conceptCode":"C16681","definition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0647F5B-A9B0-4B87-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-03","modifiedBy":"DWARZEL","dateModified":"2023-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0647F5B-A9B6-4B87-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-03","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2019188","version":"2","preferredName":"Breast Cancer Histology Text Name","preferredDefinition":"An enumerated list of the histologic types of breast cancer and benign breast disease.","longName":"BRST_CA_HIST_TXT_NM","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Papillary Carcinoma","valueDescription":"Papillary Breast Carcinoma","ValueMeaning":{"publicId":"2581145","version":"1","preferredName":"Papillary Breast Carcinoma","longName":"2581145","preferredDefinition":"A malignant breast neoplasm characterized by the formation of irregular, finger-like projections of fibrous stroma covered with neoplastic epithelial cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Papillary Carcinoma","conceptCode":"C9134","definition":"A breast carcinoma characterized by the formation of irregular, finger-like projections of fibrous stroma covered with neoplastic epithelial cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A06-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-09","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"DWARZEL","dateModified":"2006-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85341B9-883F-BAF4-E040-BB89AD433051","beginDate":"2013-10-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"ADH","valueDescription":"Atypical Ductal Breast Hyperplasia ","ValueMeaning":{"publicId":"2566837","version":"1","preferredName":"Atypical Ductal Breast Hyperplasia ","longName":"2566837","preferredDefinition":"A benign (not cancer) condition in which there are more cells than normal in the breast lobules and the cells look abnormal under a microscope. Having atypical lobular hyperplasia increases the risk of breast cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Atypical Ductal Hyperplasia","conceptCode":"C8436","definition":"A neoplastic process that arises from the terminal ductal lobular unit of the breast parenchyma.  It is usually solitary and confined to a single lobular unit.  It is characterized by the presence of a monomorphic epithelial proliferation in a cribriform, micropapillary, or solid growth pattern.  Focal architectural features of low grade ductal carcinoma in situ are present.  There is an increased risk for development of invasive breast carcinoma.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D222-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-08-18","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85341B9-85FA-BAF4-E040-BB89AD433051","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Medullary Carcinoma","valueDescription":"Medullary Breast Carcinoma","ValueMeaning":{"publicId":"3669459","version":"1","preferredName":"Medullary Breast Carcinoma","longName":"3669459","preferredDefinition":"An infiltrating breast carcinoma distinguished by its allegedly good prognosis. Medullary breast carcinoma is uncommon, accounting for fewer than 1% of all infiltrating breast carcinomas. Grossly, this is a well circumscribed tumor, with soft cut surface ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Medullary Carcinoma","conceptCode":"C9119","definition":"An infiltrating breast carcinoma with a relatively favorable prognosis.  It is an uncommon carcinoma, accounting for less than 1% of all infiltrating breast carcinomas.  It is well circumscribed, with soft cut surface and often of considerable size.  Microscopically, the predominant growth pattern is syncytial with broad anastomosing bands or sheets of malignant cells.  The malignant cells are round with abundant cytoplasm and vesicular nuclei.  The sheets of malignant cells are associated with a marked lymphoplasmacytic infiltrate.  Glandular or tubular structures are absent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-7862-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85341B9-8854-BAF4-E040-BB89AD433051","beginDate":"2013-10-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Lobular Neoplasia","valueDescription":"Lobular Neoplasia","ValueMeaning":{"publicId":"3669454","version":"1","preferredName":"Lobular Neoplasia","longName":"3669454","preferredDefinition":"A spectrum of non-invasive neoplastic lesions that arise from the terminal ductal lobular units of the breast.  There is atypical small epithelial cell proliferation.  Pagetoid involvement of the terminal ducts may or may not be present.  In the minority of cases, there is a risk for subsequent development of invasive ductal or invasive lobular carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Lobular Neoplasia","conceptCode":"C27939","definition":"A spectrum of non-invasive neoplastic lesions that arise from the terminal ductal lobular units of the breast.  There is atypical small epithelial cell proliferation.  Pagetoid involvement of the terminal ducts may or may not be present.  In the minority of cases, there is a risk for subsequent development of invasive ductal or invasive lobular carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-7719-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85341B9-8869-BAF4-E040-BB89AD433051","beginDate":"2013-10-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Lobular Carcinoma","valueDescription":"Lobular Breast Carcinoma","ValueMeaning":{"publicId":"2957350","version":"1","preferredName":"Lobular Breast Carcinoma","longName":"2957350","preferredDefinition":"An adenocarcinoma of the breast arising from the lobules.  This is a relatively uncommon carcinoma, represents approximately 10% of the breast adenocarcinomas and is often bilateral or multifocal.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Lobular Carcinoma","conceptCode":"C3771","definition":"An adenocarcinoma of the breast arising from the lobules.  This is a relatively uncommon carcinoma, represents approximately 10% of the breast adenocarcinomas and is often bilateral or multifocal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"770B3885-67E3-5BD6-E040-BB89AD4371E9","latestVersionIndicator":"Yes","beginDate":"2009-10-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-10-28","modifiedBy":"ONEDATA","dateModified":"2009-10-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85341B9-8874-BAF4-E040-BB89AD433051","beginDate":"2013-10-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Ductal Carcinoma","valueDescription":"Ductal Breast Carcinoma","ValueMeaning":{"publicId":"2838039","version":"1","preferredName":"Ductal Breast Carcinoma","longName":"2838039","preferredDefinition":"A carcinoma arising from the ducts.  While ductal carcinomas can arise at other sites, this term is universally used to refer to carcinomas of the breast.  Ductal carcinomas account for about two thirds of all breast cancers.  Two types of ductal carcinomas have been described: Ductal carcinoma in situ (DCIS) and invasive ductal carcinoma, not otherwise specified.  The latter often spreads to the axillary lymph nodes and other anatomic sites.  The two forms of ductal carcinoma often coexist.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma","conceptCode":"C4017","definition":"A breast carcinoma arising from the ducts.  While ductal carcinomas can arise at other sites, this term is universally used to refer to carcinomas of the breast. Ductal carcinomas account for about two thirds of all breast cancers. Two types of ductal carcinomas have been described: ductal carcinoma in situ (DCIS) and invasive breast carcinoma of no special type. The latter often spreads to the axillary lymph nodes and other anatomic sites. The two forms of ductal carcinoma often coexist.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62837FF7-84E7-6F46-E040-BB89AD433964","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85341B9-887E-BAF4-E040-BB89AD433051","beginDate":"2013-10-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Adenoid Cystic","valueDescription":"Adenoid Cystic","ValueMeaning":{"publicId":"2566459","version":"1","preferredName":"Adenoid Cystic","longName":"2566459","preferredDefinition":"An adenoid cystic carcinoma primarily involving the breast. Three morphologic patterns are seen: cribriform, trabecular, and solid. The prognosis is excellent.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Adenoid Cystic Carcinoma","conceptCode":"C5130","definition":"An adenoid cystic carcinoma primarily involving the breast.  Three morphologic patterns are seen: cribriform, trabecular, and solid.  The prognosis is excellent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D0A8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-11","endDate":null,"createdBy":"PWEST","dateCreated":"2003-08-11","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85341B9-8888-BAF4-E040-BB89AD433051","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Apocrine","valueDescription":"Apocrine","ValueMeaning":{"publicId":"2566460","version":"1","preferredName":"Apocrine","longName":"2566460","preferredDefinition":"A glandular secreting cell in which the apical portion of the secreting cell is cast off along with the secretory products that have accumulated therein.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Apocrine Cell","conceptCode":"C43374","definition":"A glandular secreting cell in which the apical portion of the secreting cell is cast off along with the secretory products that have accumulated therein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D0A9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-11","endDate":null,"createdBy":"PWEST","dateCreated":"2003-08-11","modifiedBy":"REEVESD","dateModified":"2013-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85341B9-8892-BAF4-E040-BB89AD433051","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"CIS NOS","valueDescription":"Carcinoma in Situ, NOS","ValueMeaning":{"publicId":"2566827","version":"1","preferredName":"Carcinoma in Situ, NOS","longName":"2566827","preferredDefinition":"A malignant epithelial neoplasm which is confined to the epithelial layer without evidence of further tissue invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carcinoma In Situ","conceptCode":"C2917","definition":"A malignant epithelial neoplasm which is confined to the epithelial layer without evidence of further tissue invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D218-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-08-18","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85341B9-8640-BAF4-E040-BB89AD433051","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"CA Cartilaginous Osseus","valueDescription":"Carcinoma with Cartilaginous/Osseous Metaplasia","ValueMeaning":{"publicId":"2566817","version":"1","preferredName":"Carcinoma with Cartilaginous/Osseous Metaplasia","longName":"2566817","preferredDefinition":"An invasive adenocarcinoma characterized by focal or extensive cartilage and/or bone formation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenocarcinoma with Cartilaginous and Osseous Metaplasia","conceptCode":"C7683","definition":"An invasive adenocarcinoma characterized by focal or extensive cartilage and/or bone formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D20E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-08-18","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85341B9-88A6-BAF4-E040-BB89AD433051","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"CA Mixed Metaplasia","valueDescription":"Carcinoma with Mixed Metaplasia","ValueMeaning":{"publicId":"2566816","version":"1","preferredName":"Carcinoma with Mixed Metaplasia","longName":"2566816","preferredDefinition":"Involving or composed of different kinds.: Transformation of a mature, normal cell or groups of mature cells to other forms of mature cells.  The capacity for malignant transformation of metaplastic cells is a subject of controversy.: A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed","conceptCode":"C25259","definition":"Involving or composed of different kinds.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Metaplasia","conceptCode":"C3236","definition":"Transformation of a mature, normal cell or groups of mature cells to other forms of mature cells.  The capacity for malignant transformation of metaplastic cells is a subject of controversy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Carcinoma","conceptCode":"C2916","definition":"A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D20D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-08-18","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85341B9-88BA-BAF4-E040-BB89AD433051","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"CA Spindle Cell Metaplasia","valueDescription":"Carcinoma with Spindle Cell","ValueMeaning":{"publicId":"2566815","version":"1","preferredName":"Carcinoma with Spindle Cell","longName":"2566815","preferredDefinition":"An invasive adenocarcinoma of the breast usually affecting post-menopausal women, characterized by extensive spindle cell metaplasia of the neoplastic glandular cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Adenocarcinoma with Spindle Cell Metaplasia","conceptCode":"C40360","definition":"An invasive adenocarcinoma of the breast usually affecting post-menopausal women, characterized by extensive spindle cell metaplasia of the neoplastic glandular cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D20C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-08-18","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85341B9-88CE-BAF4-E040-BB89AD433051","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"CA Squamous Metaplasia","valueDescription":"Carcinoma with Squamous Metaplasia","ValueMeaning":{"publicId":"2566814","version":"1","preferredName":"Carcinoma with Squamous Metaplasia","longName":"2566814","preferredDefinition":"A morphologic finding indicating the transformation of glandular or transitional epithelial cells to, usually, mature squamous epithelial cells. Representative examples include squamous metaplasia of bronchial epithelium, cervix, urinary bladder, and prostate gland.: A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Squamous Metaplasia","conceptCode":"C3237","definition":"A morphologic finding indicating the transformation of glandular or transitional epithelial cells to, usually, mature squamous epithelial cells.  Representative examples include squamous metaplasia of bronchial epithelium, cervix, urinary bladder, and prostate gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Carcinoma","conceptCode":"C2916","definition":"A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D20B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-08-18","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85341B9-88D8-BAF4-E040-BB89AD433051","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Carcinoma NOS","valueDescription":"Carcinoma, NOS (Not Otherwise Specified)","ValueMeaning":{"publicId":"2566811","version":"1","preferredName":"Carcinoma, NOS (Not Otherwise Specified)","longName":"2566811","preferredDefinition":"A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carcinoma","conceptCode":"C2916","definition":"A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D208-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-08-18","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85341B9-88EC-BAF4-E040-BB89AD433051","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Ductal Hyperplasia","valueDescription":"Usual Ductal Breast Hyperplasia ","ValueMeaning":{"publicId":"2566467","version":"1","preferredName":"Usual Ductal Breast Hyperplasia ","longName":"2566467","preferredDefinition":"A neoplastic ductal proliferative lesion of the breast characterized by the formation of secondary lumens and prominent intraductal proliferation of a heterogeneous cellular population that may include epithelial cells, myoepithelial cells, or metaplastic apocrine cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Usual Ductal Hyperplasia","conceptCode":"C27941","definition":"A neoplastic ductal proliferative lesion of the breast characterized by the formation of secondary lumens and prominent intraductal proliferation of a heterogeneous cellular population that may include epithelial cells, myoepithelial cells, or metaplastic apocrine cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D0B0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-11","endDate":null,"createdBy":"PWEST","dateCreated":"2003-08-11","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85341B9-8900-BAF4-E040-BB89AD433051","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Ductal CIS","valueDescription":"Ductal CIS","ValueMeaning":{"publicId":"2566819","version":"1","preferredName":"Ductal CIS","longName":"2566819","preferredDefinition":"A carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ","conceptCode":"C2924","definition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D210-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-08-18","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85341B9-890A-BAF4-E040-BB89AD433051","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Extensive Ductal CIS","valueDescription":"Extensive Ductal Carcinoma in situ","ValueMeaning":{"publicId":"2566818","version":"1","preferredName":"Extensive Ductal Carcinoma in situ","longName":"2566818","preferredDefinition":"Large in quantity, range, or spatial extent.: A carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Extensive","conceptCode":"C47863","definition":"Large in quantity, range, or spatial extent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Breast Ductal Carcinoma In Situ","conceptCode":"C2924","definition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D20F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-08-18","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85341B9-891E-BAF4-E040-BB89AD433051","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Mucinous","valueDescription":"Mucinous adenocarcinoma","ValueMeaning":{"publicId":"2567179","version":"1","preferredName":"Mucinous adenocarcinoma","longName":"2567179","preferredDefinition":"An invasive adenocarcinoma composed of malignant glandular cells which contain intracytoplasmic mucin. Often, the infiltrating glandular structures are associated with mucoid stromal formation. It may arise from the large and small intestine, appendix, stomach, lung, ovary, breast, corpus uteri, cervix, vagina, and salivary gland.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mucinous Adenocarcinoma","conceptCode":"C26712","definition":"An invasive adenocarcinoma composed of malignant glandular cells which contain intracytoplasmic mucin. Often, the infiltrating glandular structures are associated with mucoid stromal formation. It may arise from the large and small intestine, appendix, stomach, lung, ovary, breast, corpus uteri, cervix, vagina, and salivary gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D378-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"REEVESD","dateModified":"2013-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85341B9-8928-BAF4-E040-BB89AD433051","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"None","valueDescription":"None at all","ValueMeaning":{"publicId":"2574138","version":"1","preferredName":"None at all","longName":"2574138","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EEA7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"CLOHNES","dateModified":"2022-08-12","changeDescription":null,"administrativeNotes":"8/12/22 added alt VM for Alliance cjl;","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85341B9-8932-BAF4-E040-BB89AD433051","beginDate":"2002-09-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Not Present","valueDescription":"Not Present","ValueMeaning":{"publicId":"2581130","version":"1","preferredName":"Not Present","longName":"2581130","preferredDefinition":"Value is not present in a message. This is only defined in messages, never in application data! All values not present in the message must be replaced by the applicable default, or no-information (NI) as the default of all defaults.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"not present","conceptCode":"C1549059","definition":"Value is not present in a message. This is only defined in messages, never in application data! All values not present in the message must be replaced by the applicable default, or no-information (NI) as the default of all defaults.","evsSource":"UMLS_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-09F7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2010-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85341B9-893C-BAF4-E040-BB89AD433051","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559653","version":"1","preferredName":"Other","longName":"2559653","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B612-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85341B9-8946-BAF4-E040-BB89AD433051","beginDate":"2002-07-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Infiltrating Ductal","valueDescription":"Infiltrating Ductal Carcinoma","ValueMeaning":{"publicId":"2574524","version":"1","preferredName":"Infiltrating Ductal Carcinoma","longName":"2574524","preferredDefinition":"Invasive ductal carcinoma is the most common type of invasive breast carcinoma (accounting for approximately 70% of breast carcinomas). The gross appearance is usually typical with an irregular stellate outline. Microscopically, randomly arranged epithelial elements are seen. When large sheets of malignant cells are present, necrosis may be seen. With adequate tissue sampling, in situ carcinoma can be demonstrated in association with the infiltrating carcinoma. The in situ component is nearly always ductal but occasionally may be lobular or both. --2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Carcinoma of No Special Type","conceptCode":"C4194","definition":"A term that refers to a large and heterogeneous group of invasive breast carcinomas that cannot be classified morphologically as any of the special histological types. (WHO 2019)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F029-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-04-18","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85341B9-86EA-BAF4-E040-BB89AD433051","beginDate":"2005-04-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Infiltrating Lobular","valueDescription":"Infiltrating Lobular Carcinoma","ValueMeaning":{"publicId":"2574525","version":"1","preferredName":"Infiltrating Lobular Carcinoma","longName":"2574525","preferredDefinition":"An infiltrating lobular adenocarcinoma.  The malignant cells lack cohesion and are arranged individually or in a linear manner (Indian files), or as narrow trabeculae within the stroma.  The malignant cells are usually smaller than those of ductal carcinoma, are less pleomorphic, and have fewer mitotic figures. --2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Breast Lobular Carcinoma","conceptCode":"C7950","definition":"An infiltrating lobular adenocarcinoma of the breast.  The malignant cells lack cohesion and are arranged individually or in a linear manner (Indian files), or as narrow trabeculae within the stroma.  The malignant cells are usually smaller than those of ductal carcinoma, are less pleomorphic, and have fewer mitotic figures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F02A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-04-18","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85341B9-86F4-BAF4-E040-BB89AD433051","beginDate":"2005-04-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Comedo/Mucinous","valueDescription":"Comedo/Mucinous","ValueMeaning":{"publicId":"2574526","version":"1","preferredName":"Comedo/Mucinous","longName":"2574526","preferredDefinition":"Comedo; having a black or dark core or plug.: containing or resembling mucin.: The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Comedo","conceptCode":"C26453","definition":"Having a black or dark core or plug.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Mucinous","conceptCode":"C14163","definition":"Containing or resembling mucin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Histology","conceptCode":"C16681","definition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F02B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-04-18","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85341B9-86FE-BAF4-E040-BB89AD433051","beginDate":"2005-04-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Poorly Differentiated NOS","valueDescription":"Poorly Differentiated, Not Otherwise Specified","ValueMeaning":{"publicId":"2574527","version":"1","preferredName":"Poorly Differentiated, Not Otherwise Specified","longName":"2574527","preferredDefinition":"Poorly Differentiated, Not Otherwise Specified","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F02C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-04-18","modifiedBy":"REEVESD","dateModified":"2005-04-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85341B9-8708-BAF4-E040-BB89AD433051","beginDate":"2005-04-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Mixed ductal/lobular","valueDescription":"Mixed ductal/lobular","ValueMeaning":{"publicId":"2582310","version":"1","preferredName":"Mixed ductal/lobular","longName":"2582310","preferredDefinition":"Mixed ductal/lobular","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0E93-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-02","modifiedBy":"REEVESD","dateModified":"2006-12-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85341B9-8712-BAF4-E040-BB89AD433051","beginDate":"2006-12-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Paget Disease","valueDescription":"Paget Disease","ValueMeaning":{"publicId":"2566821","version":"1","preferredName":"Paget Disease","longName":"2566821","preferredDefinition":"A malignant neoplasm composed of large cells with large nuclei, prominent nucleoli, and abundant pale cytoplasm (Paget cells).  Paget's cell neoplasms include Paget's disease of the nipple and extramammary Paget's disease which may affect the vulva, penis, anus, skin and scrotum. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Paget Disease","conceptCode":"C7073","definition":"A malignant neoplasm composed of large cells with large nuclei, prominent nucleoli, and abundant pale cytoplasm (Paget cells).  Paget cell neoplasms include Paget disease of the nipple and extramammary Paget disease which may affect the vulva, penis, anus, skin and scrotum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D212-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-08-18","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":"04/13/2011 - tc - Updated with current NCIt name and definition.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85341B9-8950-BAF4-E040-BB89AD433051","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Secretory","valueDescription":"Secretory","ValueMeaning":{"publicId":"2566484","version":"1","preferredName":"Secretory","longName":"2566484","preferredDefinition":"A rare, low grade invasive adenocarcinoma of the breast characterized by the presence of cells that secrete milk-like material. Morphologically, it usually appears as a circumscribed lesion, composed of cystic spaces, tubular structures, and solid areas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Secretory Carcinoma","conceptCode":"C4189","definition":"A rare, low grade invasive adenocarcinoma of the breast characterized by the presence of cells that secrete milk-like material. Morphologically, it usually appears as a circumscribed lesion, composed of cystic spaces, tubular structures, and solid areas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D0C1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-11","endDate":null,"createdBy":"PWEST","dateCreated":"2003-08-11","modifiedBy":"REEVESD","dateModified":"2013-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85341B9-895A-BAF4-E040-BB89AD433051","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Tubular","valueDescription":"Tubular Adenocarcinoma","ValueMeaning":{"publicId":"2560320","version":"1","preferredName":"Tubular Adenocarcinoma","longName":"2560320","preferredDefinition":"An aggressive adenocarcinoma that arises from the sweat glands. It usually presents as a firm, erythematous nodular lesion in the axilla. Morphologically, it is characterized by the presence of tubular structures and apocrine differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sweat Gland Tubular Carcinoma","conceptCode":"C3682","definition":"An aggressive adenocarcinoma that arises from the sweat glands. It usually presents as a firm, erythematous nodular lesion in the axilla. Morphologically, it is characterized by the presence of tubular structures and apocrine differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8AD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2013-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E85341B9-8964-BAF4-E040-BB89AD433051","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"ONEDATA","dateModified":"2013-10-09","deletedIndicator":"No"},{"value":"Mucoepidermoid Carcinoma","valueDescription":"Mucoepidermoid Carcinoma","ValueMeaning":{"publicId":"3704622","version":"1","preferredName":"Mucoepidermoid Carcinoma","longName":"3704622","preferredDefinition":"A carcinoma morphologically characterized the presence of cuboidal mucous cells, goblet-like mucous cells, squamoid cells, cystic changes, and a fibrotic stromal formation. It can occur in several anatomic sites, including parotid gland, oral cavity, paranasal sinus, skin, breast, lung, larynx, and lacrimal ducts. It is classified as low or high grade.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mucoepidermoid Carcinoma","conceptCode":"C3772","definition":"A carcinoma morphologically characterized the presence of cuboidal mucous cells, goblet-like mucous cells, squamoid cells, cystic changes, and a fibrotic stromal formation. It can occur in several anatomic sites, including parotid gland, oral cavity, paranasal sinus, skin, breast, lung, larynx, and lacrimal ducts. It is classified as low or high grade.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D902E31D-3B3E-5153-E040-BB89AD437E3A","latestVersionIndicator":"Yes","beginDate":"2013-03-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0E727F32-1E72-8BE6-E050-BB89AD435501","beginDate":"2015-02-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-02-06","modifiedBy":"ONEDATA","dateModified":"2015-02-06","deletedIndicator":"No"},{"value":"Adenosquamous Carcinoma","valueDescription":"Adenosquamous Carcinoma","ValueMeaning":{"publicId":"4264016","version":"1","preferredName":"Adenosquamous Carcinoma","longName":"4264016","preferredDefinition":"A carcinoma composed of malignant glandular cells and malignant squamous cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosquamous Carcinoma","conceptCode":"C3727","definition":"An invasive carcinoma composed of malignant glandular cells and malignant squamous cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F63DCAA0-11A0-5D4B-E040-BB89AD432C9C","latestVersionIndicator":"Yes","beginDate":"2014-04-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0E727F32-1E87-8BE6-E050-BB89AD435501","beginDate":"2015-02-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-02-06","modifiedBy":"ONEDATA","dateModified":"2015-02-06","deletedIndicator":"No"},{"value":"Adenocarcinoma with Spindle Cell Metaplasia","valueDescription":"Adenocarcinoma with Spindle Cell Metaplasia","ValueMeaning":{"publicId":"2837864","version":"1","preferredName":"Adenocarcinoma with Spindle Cell Metaplasia","longName":"2837864","preferredDefinition":"An invasive adenocarcinoma characterized by focal or extensive transformation of the malignant glandular cells to spindle-shaped cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenocarcinoma with Spindle Cell Metaplasia","conceptCode":"C4201","definition":"An invasive adenocarcinoma characterized by focal or extensive transformation of the malignant glandular cells to spindle-shaped cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6281C75A-4967-A127-E040-BB89AD431A41","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0E727F32-1E9C-8BE6-E050-BB89AD435501","beginDate":"2015-02-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-02-06","modifiedBy":"ONEDATA","dateModified":"2015-02-06","deletedIndicator":"No"},{"value":"Signet Ring Cell Carcinoma","valueDescription":"Signet Ring Cell Carcinoma","ValueMeaning":{"publicId":"3248524","version":"1","preferredName":"Signet Ring Cell Carcinoma","longName":"3248524","preferredDefinition":"A usually aggressive, poorly differentiated invasive adenocarcinoma characterized by the presence of malignant glandular cells in which the nucleus is pressed to one side by the presence of intracytoplasmic mucus. It may arise from the stomach, small and large intestine, ampulla of Vater, appendix, gallbladder, pancreas, lung, bladder, breast, and prostate gland.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Signet Ring Cell Carcinoma","conceptCode":"C3774","definition":"A usually aggressive, poorly differentiated invasive adenocarcinoma characterized by the presence of malignant glandular cells in which the nucleus is pressed to one side by the presence of intracytoplasmic mucus. It may arise from the stomach, small and large intestine, ampulla of Vater, appendix, gallbladder, pancreas, lung, bladder, breast, and prostate gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6BBE041-B8DE-9503-E040-BB89AD435A00","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"COOPERM","dateModified":"2011-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0E727F32-1EB1-8BE6-E050-BB89AD435501","beginDate":"2015-02-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-02-06","modifiedBy":"ONEDATA","dateModified":"2015-02-06","deletedIndicator":"No"},{"value":"Pleomorphic Carcinoma","valueDescription":"Pleomorphic Carcinoma","ValueMeaning":{"publicId":"3669464","version":"1","preferredName":"Pleomorphic Carcinoma","longName":"3669464","preferredDefinition":"A usually aggressive malignant epithelial neoplasm composed of cells with significant cytologic atypia and nuclear pleomorphism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pleomorphic Carcinoma","conceptCode":"C4094","definition":"A usually aggressive malignant epithelial neoplasm composed of cells with significant cytologic atypia and nuclear pleomorphism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4858C70-78F1-328A-E040-BB89AD433B84","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2013-01-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0E727F32-1EC6-8BE6-E050-BB89AD435501","beginDate":"2015-02-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-02-06","modifiedBy":"ONEDATA","dateModified":"2015-02-06","deletedIndicator":"No"},{"value":"Cribriform","valueDescription":"Cribriform","ValueMeaning":{"publicId":"2558564","version":"1","preferredName":"Cribriform","longName":"2558564","preferredDefinition":"Having the appearance of a sieve: containing many perforations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cribriform","conceptCode":"C25731","definition":"Having the appearance of a sieve: containing many perforations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B1D1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"HARTLEYG","dateModified":"2016-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3AEA4AA0-62E3-9874-E050-BB89AD434E35","beginDate":"2003-08-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-08-25","modifiedBy":"ONEDATA","dateModified":"2016-08-25","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2229718","version":"1","preferredName":"Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F6EF4E2B-76AE-72C1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-05-16","modifiedBy":"ONEDATA","dateModified":"2005-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E85341B9-85DB-BAF4-E040-BB89AD433051","latestVersionIndicator":"Yes","beginDate":"2003-08-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"TAYLORT","dateModified":"2017-08-24","changeDescription":"8/24/1t tt VD is CCR specific; reuse NCI Standard 5914154.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[{"name":"ENGLISH","type":"CONTEXT NAME","context":"CCR"}],"ReferenceDocuments":[{"name":"In Situ Component (Choose all","type":"Preferred Question Text","description":"In Situ Component (Choose all that apply)","url":null,"context":"CCR"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E8535B39-C124-3403-E040-BB89AD43304C","latestVersionIndicator":"Yes","beginDate":"2013-10-09","endDate":"2014-02-25","createdBy":"REEVESD","dateCreated":"2013-10-09","modifiedBy":"COOPERM","dateModified":"2018-11-26","changeDescription":"Released latest version. mc 11/26/2018","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}